Novye vozmozhnosti terapii nekontroliruemoy arterial'noy gipertenzii


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Currently, the issue of new approaches to the treatment of patients with arterial hypertension (AH) refractory to conventional drug therapy is widely discussed. Refractory AH includes lack of control of blood pressure (BP) using three different classes of antihypertensive drugs in optimal doses, and one of the drugs should be diuretic. The article considers the problems of diagnosis of resistant hypertension, and the significance of methods of 24-hour BP monitoring. The non-drug and drug treatment of uncontrolled hypertension are discussed. The data on the effectiveness of new invasive approaches to the management of this group of patients are presented.

Толық мәтін

Рұқсат жабық

Авторлар туралы

L. Minushkina

Email: minushkina@mail.ru

Әдебиет тізімі

  1. Brown M.A., Buddle M.L., Martin A. Is resistant hypertension really resistant? // Am. J. Hypertension. - 2001. - Vol. 14(12). - P. 1263-69.
  2. Persell S.D. Prevalence of resistant hypertension in the United States, 2003-2008 // Hypertension. - 2011. - Vol. 57(6). - P. 1076-80.
  3. Hanselin M.R., Saseen J.J., Allen R.R., et al. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents // Hypertension. - 2011. - Vol. 58(6). -P. 1008-13.
  4. Marui F.R., Bombig M.T., Francisco Y.A., et al. Assessment of resistant hypertension with home blood pressure monitoring // Arq. Bras. Cardiol. -2010. - Vol. 95(4). - P. 536-40.
  5. Daugherty S.L., Powers J.D., Magid D.J., et al. Incidence and prognosis of resistant hypertension in hypertensive patients // Circulation. - 2012. - Vol. 125(13). - P. 1635-42.
  6. Gupta A.K., Nasothimiou E.G., Chang C.L., et al. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at highrisk // J. Hypertens. -2011. - Vol. 29(10). -P. 2004-13.
  7. Muxfeldt E.S., Fiszman R., de Souza F. Appropriate time interval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension // Hypertension. - 2012. - Vol. 59(2). -P. 384-89.
  8. Ayala D.E., Gomara S., Sineiro E., et al. Hygia Project Investigators. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring // Chronobiol. Int. - 2013. - Vol. 30(1-2). -P. 207-20.
  9. Llisterri J.L., Alonso F.J., Gorostidi M., et al. Differences between office and ambulatory control of hypertension in very elderly patients. The CARDIORISC - MAPAPRES project // Med. Clin. (Barc). - 2009. - Vol. 133(20). - P. 769-76.
  10. Hermida R.C., Rios M.T., Crespo J.J., et al. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension // Chronobiol. Int. - 2013. - Vol. 30(1-2). - P. 192-206.
  11. Pimenta E., Gaddam K.K., Oparil S., et al. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial // Hypertension. - 2009. - Vol. 54(3). - P. 475-81.
  12. Johnson A.G., Nguyen T.V., Day R.O. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis //Ann. Intern. Med. - 1994. -Vol. 121. - P. 289-300.
  13. Chobanian A.V., Bakris G.L., Black H.R., et al. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure // Hypertension. - 2003. - Vol. 42. - P. 1206-52.
  14. Mancia G., Laurent S., Agabiti-Rosei E., et al. Reappraisal of European guidelines on hypertension managements: a European Society of Hypertension Task Force document//J. Hum.Hypertens. - 2009. - Vol. 27. - P. 2121-58
  15. Krause T., Lovibond K., Caulfield M., McCormack T., Williams B.; Guideline Development Group. Management of hypertension: summary of NICE guidance// BMJ. - 2011 ;343:d4891.
  16. Circelli M., Nicolini G., Egan C.G., Cremonesi G. Efficacy and safety of delapril/indapamide compared to different ACE-inhibitor/hydrochlorothiazide combinations: a meta-analysis // Int. J. Gen. Med. - 2012. - Vol. 5. -P. 725-34.
  17. Pimenta E., Gaddam K.K., Pratt-Ubunama M.N., et al. Aldosterone excess and resistance to 24-h blood pressure control // J. Hypertens. - 2007. -Vol. 25(10). - P. 2131-37.
  18. Pisoni R., Acelajado M.C., Cartmill F.R., et al. Long-term effects of aldosterone blockade in esistant hypertension associated with chronic kidney disease // J. Hum. Hypertens. - 2012. - Vol. 26(8). - P. 502-06.
  19. Lane D.A., Shah S., Beevers D.G. Low-dose spironolactone in the management of resistant hypertension: a surveillance study // J. Hypertens. - 2007. - Vol. 25(4). - P. 891-94.
  20. Engbaek M., Hjerrild M., Hallas J., Jacobsen I.A. The effect of low-dose spironolactone on resistant hypertension // J. Am. Soc. Hypertens. - 2010. -Vol. 4(6). - P. 290-94.
  21. Clark D. 3rd, Ahmed M.I., Calhoun D.A. Resistant hypertension and aldosterone: an update // Can. J. Cardiol. - 2012. - Vol. 28(3). -P. 318-25.
  22. Gaddam K., Pimenta E., Thomas S.J., et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report // J. Hum. Hypertens. - 2010. -Vol. 24(8). - P. 532-37.
  23. Vaclavik J., Sedlak R., Jarkovsky J., et al. Effect of spironolactone in patients with resistant arterial hypertension in relation to age and sex: Insights from the aspirant trial. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012 Dec 7. doi: 10.5507/bp.2012.105.
  24. Vaclavik J., Sedlak R., Jarkovsky J., et al. The effect of spironolactone in patients with resistant arterial hypertension in relation to baseline blood pressure and secondary causes of hypertension // Biomed. Pap. Med. Fac. Univ. Palacky Olomouc. Czech. Repub. - 2013. - Vol. 157(1). -P. 50-5.
  25. Rosenbaum D., Villeneuve F., Gury C., Girerd X. Frequency of hypertension resistant to treatment and indication for renal denervation // Ann. Cardiol. Angeiol. (Paris). - 2012. - Vol. 61(3). - P. 22933. doi: 10.1016/j.ancard.2012.04.018.
  26. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months // Hypertension. - 2011. - Vol. 57(5). - P. 911-17.
  27. Esler M.D., Krum H., Schlaich M., et al. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial // Circulation. - 2012. - Vol. 126(25). - P. 2976-82.
  28. Dorenkamp M., Bonaventura K., Leber A.W., et al. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension // Eur. Heart. J. - 2013. - Vol. 34(6). - P. 451-61.
  29. Witkowski A., Prejbisz A., Florczak E., et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea // Hypertension. - 2011. - Vol. 58(4). -P. 559- 65.
  30. Mahfoud F., Cremers B., Janker J., et al. Renal hemodynamics and renal function after catheterbased renal sympathetic denervation in patients with resistant hypertension // Hypertension. - 2012. - Vol. 60(2). - P. 419-24.
  31. Alnima T., Scheffers I., De Leeuw P.W., et al. Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension // J. Hypertens. - 2012. - Vol.30(8). - P. 1665-70.
  32. Heusser K., Tank J., Engeli S., et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients // Hypertension. - 2010. - Vol. 55(3). - P. 619-26.
  33. Wustmann K., Kucera J.P., Scheffers I., et al. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension // Hypertension. - 2009. - Vol. 54(3). -P. 530-36.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>